Two leading retinal specialists break down MCO-010's 3-year efficacy and safety data, the significance of contralateral eye findings, and how this gene-agnostic optogenetic approach could fill a ...
A wireless intracortical architecture targets total blindness by circumventing nonfunctional retinas and optic nerves, ...
Sustained LLVA responder rates at 12 months reinforced the earlier 9-month signal and aligned with the endpoints selected for ...
ALLUVIUM showed vamikibart Q8W/Q4W improved DME outcomes but underperformed ranibizumab for BCVA (+4.6 to +7.1 vs +13 letters ...
Paired ocular–systemic measurements in 24 healthy adults revealed OPP as a stronger correlate of GLS and sPAP than either BP ...
Ariel Ong, a fellow from University College London, discussed her ARVO poster, looking at her work on developing a scalable ...
Renee Long, from the University of California San Diego, took some time to discuss her poster on the viability of Grok as a ...
Safety signals with faricimab in routine practice, including intraocular inflammation and endophthalmitis, aligned with prior ...
According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
A double-masked, randomized study in 20 healthy adults compared placebo versus single-drop atropine (0.01%–0.1%) across five ...
At this year's ARVO meeting in Denver, Colorado, Giulia Corradetti spoke on how baseline OCT biomarkers can predict anatomic ...
Kaden Bunch, a fourth-year medical student from the Warren Alpert Medical School of Brown University, talked about his poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results